Advanced Biomed is trading at $18.46 (+10.01%) in pre-market as the rally extends following the company’s decision to cancel a planned securities offering.
- The cancellation has alleviated investor concerns regarding potential share dilution, which had previously weighed on the stock.
- The stock continues to show significant momentum, building on sharp recent gains of +73.02% on July 22 and +36.98% on July 23.